Loading...
XNAS
LWAY
Market cap364mUSD
Dec 05, Last price  
23.92USD
1D
-0.66%
1Q
-23.14%
Jan 2017
107.82%
Name

Lifeway Foods Inc

Chart & Performance

D1W1MN
XNAS:LWAY chart
P/E
40.36
P/S
1.95
EPS
0.59
Div Yield, %
Shrs. gr., 5y
-0.69%
Rev. gr., 5y
14.81%
Revenues
187m
+16.67%
20,131,65427,720,71338,729,15644,461,45558,115,87858,499,89369,970,40981,351,26597,524,142118,959,613118,587,000123,879,000118,893,000103,350,00093,662,000102,026,000119,065,000141,568,000160,123,000186,820,000
Net income
9m
-20.60%
2,548,4732,895,8243,152,6601,912,2755,569,7023,622,4662,855,4215,619,7984,974,9582,840,2101,972,0003,479,000-346,000-3,086,000453,0003,232,0003,311,000924,00011,367,0009,025,000
CFO
13m
-23.49%
1,592,4912,157,5032,347,1374,733,6607,603,0615,615,9434,042,0216,627,6845,841,1285,060,0556,745,0005,104,0003,808,0002,417,0003,811,0006,385,0005,564,0003,987,00016,941,00012,962,000
Dividend
May 29, 20130.08 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Lifeway Foods, Inc. produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types, including low fat, non-fat, whole milk, protein, and BioKefir. The company also offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; cupped kefir and Icelandic Skyr, a line of strained kefir and yogurt products; and frozen kefir in soft serve and pint-size containers. It sells its products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers primarily through direct sales force, brokers, and distributors. The company was founded in 1986 and is based in Morton Grove, Illinois.
IPO date
Dec 29, 1988
Employees
289
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT